MedTech Strategist Market Pathways - David Filmore, Executive Editor: A Press Release

article image
ARTICLE SUMMARY:

MedTech Strategist Market Pathways - David Filmore, Executive Editor: A Press Release

Fairfield, CT:  MedTech Strategist, a leading information provider and investment conferences organizer focused exclusively on the rapidly evolving global medical device industry, is pleased to announce that David Filmore has joined the editorial team to lead the launch of a new publication, MedTech Strategist Market Pathways: Global Medical Device Regulation, Reimbursement & Policy Review. Filmore, the former executive editor of The Gray Sheet, has spent the last 20 years covering the global medical technology industry, specializing in regulatory, reimbursement and market access dynamics and strategy.altered

Filmore will serve as the executive editor of MedTech Strategist Market Pathways, which MedTech Strategist launched in June 2019. The new publication will provide unparalleled coverage of and perspectives on the complex regulatory and reimbursement landscape, to identify the risks and opportunities that medtech manufacturers face along myriad complex pathways as they bring products to market in the US, Europe, Asia-Pacific, South America, and other regions around the world.

“We’re thrilled to welcome David Filmore to our team of the industry’s most experienced and well-connected subject matter experts. Dave’s unparalleled background covering the medtech regulatory and policy space for more than 20 years makes him the perfect person to head up the launch of our new publication, Market Pathways,” said Stephen Levin, Co-Editor-in-Chief of MedTech Strategist and MedTech Strategist Market Pathways.

“I’m looking forward to supporting the medical device industry for years to come.” 

David Filmore

“I am delighted to be joining this dedicated and knowledgeable team at such an exciting juncture for the company, as we introduce MedTech Strategist Market Pathways,” Filmore said. “As regulatory and reimbursement gatekeepers from around the world are crafting new oversight approaches that can challenge device and diagnostics companies’ pathway to market, it’s never been more important for industry to keep abreast of the myriad factors impacting their success.”

MedTech Strategist Market Pathways will complement the respected coverage provided in the company’s flagship publication, MedTech Strategist, which covers disruptive device companies and technologies, shifting competitive landscapes, innovative new marketplace dynamics, and changing business models.

For more information and to sign up to receive a complimentary copy of the premier issue of MedTech Strategist Market Pathways, visit www.medtechstrategist.com/market-pathways. The publication is available as a single-user, multiple-user or enterprise-wide subscription, in online and print format. Special introductory annual subscription rates are available for a limited time; contact us to join our community today.

 

 

#MedicalDevice #MedicalTechnologies #Medtech #Device #StartUp #CommunityBlog #technology #blog #medtechstrategist #strategy #medicaldevices #healthcare #innovation #RegulatoryandReimbursement #R&R #davidfilmore #pressrelease


 Trial MyStrategist.com  and unlock 7-days of exclusive  subscriber-only access  to the medical device industry's most trusted strategic publications:  MedTech Strategist  &  Market Pathways . For more information on our demographics and current readership  click here .

×



Articles from David Filmore:

Regulatory & Reimbursement

CMS Pushes Back on New-Tech Pay Applications, But Activity Remains Strong

The Medicare agency is on a path to potentially approve more new technology add-on payments for devices entering the hospital inpatient setting next year than it has since the NTAP program launched, even after disqualifying eight products under new eligibility requirements.

Read Article